ClinicalTrials.gg
CompletedNCT07498764V-CAREUpdated Nov 9, 2026

V-CARE (Virtual Care After REsuscitation)

An interventional study of Virtual Care After REsuscitation and Digital Information Leaflet in Health-Related Quality-of-Life, Satisfaction With Care and Self-management Behaviors, sponsored by Mid and South Essex NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Mid and South Essex NHS Foundation Trust · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Aug 2024, registered Sep 2025).
Updated Nov 9, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Out-of-Hospital Cardiac Arrest with a site in United Kingdom — 4 open to participants now, 6 under way, none of them phase 3. Out-of-Hospital Cardiac Arrest · United Kingdom.

Enrollment
8th of 12
53 · median 575
Started
2024
with 3 others
No phase
12 of 20
2 open now
Registered
18th of 20
by date
Lead sponsor
2 of 20
Mid and South Essex NHS Foundation Trust

Among the 20 studies in Out-of-Hospital Cardiac Arrest with a site in United Kingdom, this one is the 8th largest by enrollment of the 12 interventional ones that give a count, is one of 4 that started in 2024, is one of 12 with no phase, and was the 18th registered.

Out-of-Hospital Cardiac Arrest

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

Browse Out-of-Hospital Cardiac Arrest studies →

Open to participants now

4 of the 20 studies in Out-of-Hospital Cardiac Arrest with a site in United Kingdom are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Out-of-Hospital Cardiac Arrest with a site in United Kingdom, or all of them as a file.
02

Study summary

Out-of-hospital cardiac arrest (OHCA) survivors and their relatives may face challenges following hospital discharge, relating to mood, cognition, and returning to normal day-to-day activities. Identified research gaps include a lack of knowledge around what type of intervention is needed to best navigate recovery. In this study, the feasibility and patient acceptability of a new virtual psychoeducational group intervention for OHCA survivors and their relatives are evaluated and compared with those of a control group receiving a digital information booklet.

Read the detailed description
  1. Introduction Every year more than 300 000 individuals in Europe suffer an out-of-hospital cardiac arrest (OHCA); only around 8% of them survive to hospital discharge Most survivors make a 'good' recovery-that is, they achieve a quality of life akin to what they had prior to their OHCA-despite this, difficulties with cognition, mood, and physical recovery have been extensively documented. Cognitive deficits, albeit usually mild, affect as many as 40-50% of survivors 6-12 months after their cardiac arrest. Impairments are often found in memory, followed by executive functioning and processing speed, although the heterogeneity of the measures and methodology used reduces the generalizability of these results. Anxiety and depression have also been described in OHCA survivors, with a recent systematic review reporting symptoms of depression, anxiety and post-traumatic stress disorder (PTSD) in 19%, 26%, and 20% of patients, respectively. Psychological distress has been found to contribute to fatigue severity one month after hospital discharge [9]; high psychological distress can also impact a variety of health behaviours and influence health-related quality of life and risk of cardiovascular disease. Rates of fatigue, anxiety, depression, reduced mental function, and disability appear to be the same 1 and 5 years after the event, suggesting limited natural recovery. Returning to daily activities and previous occupational roles is often problematic, with around half of survivors experiencing difficulties or the inability to resume work; these rates remain lower compared to patients recovering from myocardial infarction.

    Co-survivors, including family members and close friends of survivors, also undergo their own process of recovery. Qualitative studies show that this involves overcoming the initial shock of witnessing the arrest and having to support the survivor in their recovery after discharge from hospital, often with little or no support from healthcare professionals. Persistent symptoms of post-traumatic stress disorder (PTSD) and anxiety have also been documented to be common in this population; however, no study thus far has assessed the impact of mental interventions to mitigate their psychological distress. Recent research underlines that both survivors and co-survivors have a need for more resources and education on how to best navigate recovery after an OHCA.

    1.1. Rationale for a Psychoeducational Intervention

    Several questions remain unanswered around the psychosocial impact of survivorship on quality of life, as well as optimal post-discharge rehabilitation and care to maximize recovery for survivors and for their family members. In recent years there has been broad recognition of the importance of providing follow-up for survivors of OHCA and their key supporters (hereby defined as family members, spouses, partners, or friends who provide support from admission to hospital through rehabilitation/recovery and beyond). One such example is a priority-setting exercise completed using the methodology developed by the James Lind Alliance, which identified that the needs of key supporters post-OHCA must be served better, as well as confirming the specific need for post-discharge survivor-focused care. Similarly, a statement from the American Heart Association (AHA) also identifies a knowledge gap in cardiac arrest research concerning the role for support networks/groups after cardiac arrest. Current guidelines and position statements all stress the importance of providing appropriate follow-up care, both to survivors and key supporters, whilst highlighting the lack of evidence-based interventions available.

    Thus far, few studies have evaluated the impact of post-discharge support and educational interventions on longer-term quality of life. A recent systematic review and meta-analysis highlighted the lack of good-quality evidence and the high heterogeneity in intervention design and the outcome measures used; in addition, rehabilitation interventions have not been described in detail, preventing replication of results. Of the studies published so far, the 'Activity and Life after Survival of a Cardiac Arrest' RCT showed significant benefits in the outcomes of cardiac arrest survivors, with additional analyses suggesting a high probability of cost-effectiveness from a societal perspective. An intense 11-session individual psychological and education intervention was found to reduce risk of cardiovascular death; however, the impact on quality of life was not measured, and the volume and intensity of therapy provided may be a barrier to widespread adoption. A small pilot study focused specifically on chronic fatigue after OHCA showed that an energy-conservation and problem-solving therapy intervention (delivered over the telephone) was feasible, acceptable, and effective in improving outcomes. More recently, a residential rehabilitation intervention focused on fatigue and physical/psychological consequences of an OHCA showed promising results in several domains, such as quality of life, fatigue, and anxiety, even though the high intensity/volume of this intervention may not make it suitable for widespread adoption. A protocol for the remote delivery of individual psychotherapy and cardiac-focused psychoeducation combining mindfulness and exposure-based interventions has also recently been successfully trialled in a small sample of OHCA survivors experiencing PTSD. Other trials focused on exploring interventions to facilitate return to work (ROCK trial), alleviate psychological distress and improve cognitive abilities (ENFORCER trial), and to promote recovery and self-management (CARESSf)] are currently ongoing.

    The studies currently available suggest that a programme integrating educational elements and skill training (for example, for the management of fatigue) might be appropriate for improving outcomes after an OHCA. To our knowledge, however, an intervention involving both survivors and key supporters, delivered virtually in a group format, has not been trialled yet. The feasibility and acceptability of this model require exploration; a virtual group intervention for elderly people with depression was found to be feasible and effective [39]; however, in another study, a tele-rehabilitation group intervention failed to recruit and retain participants in a geriatric population.

    1.2. Study Aims The primary aims are to investigate whether the Virtual Care After REsuscitation (V-CARE) intervention-a bespoke psychoeducational, remotely delivered intervention co-designed with cardiac arrest survivors and their key supporters-is feasible and tolerable 2 to 3 months post-discharge from hospital. A secondary aim is to explore whether participating in the V-CARE intervention leads to beneficial effects in self-management skills and higher satisfaction with the treatment received, compared to a control group receiving a digital information booklet only.

  2. Methods 2.1. Study Design This study, a comparative, single-blind randomized pilot trial investigating the psychoeducational V-CARE intervention, is included as a sub-study in the Sedation, TEmperature, and Pressure after Cardiac Arrest and REsuscitation (STEPCARE) trial, an international, multicenter, randomized, factorial, and superiority trial designed to evaluate optimal post-resuscitation care strategies for unconscious adult patients following OHCA.

    The V-CARE study described here includes participants at selected sites of the STEPCARE trial, in the United Kingdom and Sweden, surviving with a good neurological outcome (mRS) ≤ 3. Patients will be recruited after the scheduled 30-day follow-up of STEPCARE.

    2.2. Patient and Public Involvement The development of the V-CARE intervention and of the digital information leaflet were informed by an exploratory sequential mixed-method design, engaging both OHCA survivors and their key supporters.

    2.3. Study Population and Randomization In addition to the criteria needed for taking part in STEPCARE, OHCA survivors eligible to take part in V-CARE are also required to have an mRS ≤ 3 at the 30-day follow-up and (a) must not have a diagnosis of dementia that would impact their ability to participate and benefit from the sessions and complete baseline/outcome measure (based on a clinician's evaluation and/or self-report by the patient or family) and (b) must not be actively psychotic/experiencing any other serious acute mental health condition that would affect their participation in this study, based on clinical evaluation.

    When recruited, consenting patients will be encouraged to take part in the study together with a 'key supporter'; however, this will not be a requirement.

    Consenting patients will be randomized on an equal basis (1:1) to the V-CARE arm or to the information booklet arm. V-CARE has a randomized block design with a separate randomization list in each country, completed by a local lead site. Custom-built software was developed using Python (v3.12.7) and the Tkinter library to allocate patients into two study conditions-V-CARE or the digital information booklet. A computer-generated pseudo-randomized list with 25 sets of 2 unique numbers per set was pre-generated using an online randomization tool [https://www.randomizer.org/] (accessed on 7 October 2024) to ensure an unbiased allocation process.

    2.4. Interventions 2.4.1. V-CARE (Virtual CAre After REsuscitation)

    The intervention focuses on providing early cardiac-arrest-related education, promoting the development of coping skills, encouraging peer support, and signposting survivors and key supporters to relevant resources/services.

    The V-CARE programme involves 4 structured sessions, one a week, each lasting around one hour, supported by PowerPoint presentations (File S1). The content focuses on providing education on cardiac arrest and secondary prevention, addressing practical problems (for instance, returning to driving, travelling, living with an implantable cardioverter defibrillator (ICD), etc.) and understanding/coping with fatigue, cognitive changes, and psychological difficulties. As multiple sites in each country are expected to take part in this study, groups will be formed as soon as 3 to 6 patients have been recruited, although smaller groups could be formed if required. Group size will usually be between 4 and 12 participants. The aim is for the intervention to be delivered early to each group, starting around 2 and 3 months after hospital discharge; however, it is expected that it may be delivered to some groups up to-but not beyond-6 months post-discharge.

    Each session includes broadly equal time for presentation, questions, and discussion, with the aim of encouraging participants to develop self-management skills. A printout of the PowerPoint slides used in each session is provided in Supplementary Material.

    A single, designated healthcare professional will serve as a facilitator for each group and will be present for all sessions, having been trained by the study team; it is anticipated that it will be delivered by either a clinical psychologist or an occupational therapist, but a clinical nurse specialist could also manage a group. A cardiologist or cardiology resident will attend the first session to answer generic, cardiac-arrest-related questions.

    2.4.2. Digital Information Booklet This intervention, also co-developed with a patient group, consists of an information booklet focused on providing information and coping strategies for fatigue, memory, low mood, anxiety, and cognitive problems after a cardiac arrest. Whereas the content is similar to that covered in the V-CARE arm, these patients are not included in a group and as such do not have access to peer support or to guided discussions and reflections as provided in the group setting. In this intervention arm, tolerability will be assessed by the proportion of participants who complete the post-intervention outcome measures; additionally, participants will be asked to self-report whether they read or used the booklet. A copy of this intervention is provided in the Supplementary Material (File S2).

  3. Conclusions In this study, the investigators examine if a remotely delivered psychoeducational intervention for OHCA survivors and their key supporters is feasible, and in addition if there is trend towards beneficial effects compared to a control group receiving a digital information booklet only. We describe the different phases of the study, namely the rationale for this intervention, conceptualization of the project, structure of the intervention, and outcome measure adopted. The primary outcome is the evaluation of the feasibility and tolerability of delivering this intervention-definitions have been provided to measure this outcome. Secondary outcome measures include the Client Satisfaction Questionnaire and the Self-Management Assessment Scale. Criteria for the success of the study have been reported, and a description of the pre-planned statistical analyses provided.

The preliminary results from this pilot trial will provide valuable insights to inform a larger trial to evaluate the effectiveness of an intervention to support recovery post-cardiac arrest. First, the outcome feasibility will provide insights regarding the actual interest of patients and their caregivers to take part in a digital intervention to support recovery in the early phase after a cardiac arrest. Second, the outcomes of tolerability and satisfaction with care will be instrumental for the potential need of adjustments in the design of the intervention for the larger trial. Lastly, hypothesis-generating trends in differences between the two groups in terms of self-management skills and health outcomes will be able to guide the choices of primary outcomes and power calculations for a larger trial.

03

Conditions studied

  • Health-Related Quality-of-Life
  • Satisfaction With Care
  • Self-management Behaviors

Keywords

  • out-of-hospital cardiac arrest
  • psychoeducation
  • telemedicine
  • quality of life
  • family caregivers
  • survivors
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Meet all eligibility requirements for the STEPCARE trial
  • Modified Rankin Scale (mRS) ≤ 3 at the 30-day follow-up

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of dementia expected to limit the ability to participate in sessions or complete baseline/outcome measures, based on clinician evaluation and/or self-report by the patient or family
  • Active psychosis or any other acute severe mental health condition that would impair participation, based on clinical evaluation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
53 participants (actual)

Study arms

  • Experimental
    Virtual Care After Resuscitation remotely delivered group Arm

    V-CARE groups will be formed as soon as 3 to 6 patients have been recruited. Group size will usually be between 4 and 12 participants. The aim is for the V-CARE intervention to be delivered early to each group, starting around 2 and 3 months after hospital discharge

    Other: Virtual Care After REsuscitation

  • Experimental
    Digital Information Leaflet intervention Arm

    In this group, patients will be sent a Digital Information Leaflet around 2 to 3 months after hospital discharge (content described in Digital Information Leaflet Arm intervention)

    Other: Digital Information Leaflet

Interventions

  • OtherVirtual Care After REsuscitation

    The V-CARE programme involves 4 structured sessions, one a week, each lasting around one hour, supported by PowerPoint presentations. The content focuses on providing education on cardiac arrest and secondary prevention, addressing practical problems (for instance, returning to driving, travelling, living with an implantable cardioverter defibrillator (ICD), etc.) and understanding/coping with fatigue, cognitive changes, and psychological difficulties. Group size will usually be between 4 and 12 participants.

  • OtherDigital Information Leaflet

    This intervention, co-developed with a patient group, consists of an information booklet focused on providing information and coping strategies for fatigue, memory, low mood, anxiety, and cognitive problems after a cardiac arrest. Whereas the content is similar to that covered in the V-CARE arm, these patients are not included in a group and as such do not have access to peer support or to guided discussions and reflections as provided in the group setting. In this intervention arm, tolerability will be assessed by the proportion of participants who complete the post-intervention outcome measures; additionally, participants will be asked to self-report whether they read or used the booklet.

06

What researchers measure

Primary outcomes

  1. Feasibility of recruitment

    Proportion of eligible patients approached for participation who provide consent to enrol in the V-CARE study. Unit of Measure: Percentage of eligible patients approached who provide consent.

    Time frame: At the point of recruitment

  2. Post-intervention assessment completion rate

    Proportion of randomized participants who complete the post-intervention assessment. Unit of Measure: Percentage of randomized participants completing the post-intervention assessment.

    Time frame: At the end of intervention (approximately 6 weeks).

Secondary outcomes

  1. Satisfaction with care (Client Satisfaction Questionnaire-8) - OHCA Survivors

    Satisfaction with care among OHCA survivors, assessed using the Client Satisfaction Questionnaire-8. Total score ranges from 8 to 32, with higher scores indicating greater satisfaction. Unit of Measure: Client Satisfaction Questionnaire-8 total score (range 8 to 32).

    Time frame: At the end of treatment, around 6 weeks after enrolment

  2. Satisfaction with care (Client Satisfaction Questionnaire-8) - Key Supporters

    Satisfaction with care among key supporters, assessed using the Client Satisfaction Questionnaire-8. Total score ranges from 8 to 32, with higher scores indicating greater satisfaction. Unit of Measure: Client Satisfaction Questionnaire-8 total score (range 8 to 32).

    Time frame: At the end of treatment, around 6 weeks after enrolment

  3. Self-management skills (Self-Management Assessment Scale)

    Self-management skills among OHCA survivors, assessed using the Self-Management Assessment Scale. Total score ranges from 6 to 36, with higher scores indicating better self-management skills. Unit of Measure: Self-Management Assessment Scale total score (range 6 to 36).

    Time frame: At the end of treatment, approximately 6 weeks after recruitment

07

Study locations

1 site
08

References and documents

Publications

  • Mion M, Lilja G, Bohm M, Nordstrom EB, Toniste D, Heimburg K, Swindell P, Dankiewicz J, Skrifvars MB, Nielsen N, Jakobsen JC, White J, Wise MP, Gorgoraptis N, Keenan M, Hopkins P, Pareek N, Maccaroni M, Keeble TR. V-CARE (Virtual Care After REsuscitation): Protocol for a Randomized Feasibility Study of a Virtual Psychoeducational Intervention After Cardiac Arrest-A STEPCARE Sub-Study. J Clin Med. 2025 Jun 22;14(13):4429. doi: 10.3390/jcm14134429. PubMed 40648804 ↗

Individual participant data

Plan to share: No — All data will be analyzed at group level; no IPD will be shared

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2024 to primary completion in Aug 2026, 24 months.

Of 93 non-industry interventional studies with no phase under Out-of-Hospital Cardiac Arrest, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 57. This study's 24 months is below that.

Counting every sponsor, half of 95 studies reached it within 34 months; a quarter within 19 and three quarters within 57.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: primary completion Jul 2026 → Aug 2026 and completion Sep 2026 → Aug 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 1, 2025
First posted
Mar 27, 2026
StartActual
Aug 1, 2024
Primary completionActual
Aug 17, 2026was Jul 2026
CompletionActual
Aug 18, 2026was Sep 2026
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Nov 9, 2026
Primary completion
Jul 2026→Aug 17, 2026 (actual)
Nov 9, 2026
Study completion
Sep 2026→Aug 18, 2026 (actual)
Nov 9, 2026
Enrollment
50 (estimated)→53 (actual)
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Enrolling by invitation→Completed
    Primary completion Jul 2026→Aug 17, 2026 (now actual)
    Study completion Sep 2026→Aug 18, 2026 (now actual)
    Enrollment 50 (estimated)→53 (actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07498764
Lead sponsor
Mid and South Essex NHS Foundation Trust
Responsible party
Sponsor
First posted
Mar 27, 2026
Start date
Aug 1, 2024
Primary completion
Aug 17, 2026
Completion
Aug 18, 2026
Last update
Nov 9, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion